-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Moving shares this morning are clinical trial results, earnings, and prices of public stock offerings.
Let's get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Atlis Motor Vehicles (NASDAQ:AMV) stock is rocketing more than 186% as it rallies following its initial public offering (IPO).
- SILO Pharma (NASDAQ:SILO) shares are rising over 78% after uplisting to the Nasdaq Exchange.
- Prothena Corp (NASDAQ:PRTA) stock is soaring more than 64% alongside positive Alzheimer's drug data from a rival.
- Biogen (NASDAQ:BIIB) shares are gaining over 43% due to it being the rival that posted the Alzheimer's drug data.
- Acumen Pharmaceuticals (NASDAQ:ABOS) stock is surging more than 29% as it also joins in on the Alzheimer's drug rally.
- BiomX (NYSEMKT:PHGE) shares are climbing over 27% ahead of its delisting from the Tel Aviv Stock Exchange next week.
- MorphoSys (NASDAQ:MOR) stock is increasing more than 19% in pre-market trading on Wednesday.
- India Globalization Capital (NYSEMKT:IGC) shares are getting an almost 19% boost this morning.
- TCR2 Therapeutics (NASDAQ:TCRR) stock is jumping over 17% alongside the release of clinical trial results.
- Longeveron (NASDAQ:LGVN) shares are up more than 17% in Wednesday morning trading.
10 Top Losers
- Mind Medicine (NASDAQ:MNMD) stock is plummeting over 35% after pricing a public stock offering.
- iBio (NYSEMKT:IBIO) shares are diving close to 33% with the release of preliminary results for fiscal Q4.
- Nano Labs (NASDAQ:NA) stock is tumbling more than 21% after revealing the pricing of a public stock offering.
- Gamida Cell (NASDAQ:GMDA) shares are taking a nearly 21% beating as it also priced a public stock offering.
- Powerbridge Technologies (NASDAQ:PBTS) stock is falling over 13% after rallying yesterday on NFT news.
- Avenue Therapeutics (NASDAQ:ATXI) shares are dropping more than 13% after rallying on Tuesday.
- EZGO Technologies (NASDAQ:EZGO) stock is sliding over 13% on no clear news today.
- MFA Financial (NYSE:MFA) shares are slipping more than 10% following two S-3ASR filings yesterday.
- Siyata Mobile (NASDAQ:SYTA) stock is dipping over 10% today.
- 9 Meters Biopharma (NASDAQ:NMTR) shares close out our pre-market stock movers down more than 9% following a rally yesterday on clinical trial data.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市場新聞、股票建議和交易提示
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
現在是另一個潛入最大的開盤前股票走勢的時候了,我們來看看週三早上發生了什麼。
Moving shares this morning are clinical trial results, earnings, and prices of public stock offerings.
今天上午的走勢是臨床試驗結果、收益和公開發行股票的價格。
Let's get into that news below!
讓我們來看看下面的新聞吧!
Pre-Market Stock Movers: 10 Top Gainers
盤前炒股:十大漲幅最大的股票
- Atlis Motor Vehicles (NASDAQ:AMV) stock is rocketing more than 186% as it rallies following its initial public offering (IPO).
- SILO Pharma (NASDAQ:SILO) shares are rising over 78% after uplisting to the Nasdaq Exchange.
- Prothena Corp (NASDAQ:PRTA) stock is soaring more than 64% alongside positive Alzheimer's drug data from a rival.
- Biogen (NASDAQ:BIIB) shares are gaining over 43% due to it being the rival that posted the Alzheimer's drug data.
- Acumen Pharmaceuticals (NASDAQ:ABOS) stock is surging more than 29% as it also joins in on the Alzheimer's drug rally.
- BiomX (NYSEMKT:PHGE) shares are climbing over 27% ahead of its delisting from the Tel Aviv Stock Exchange next week.
- MorphoSys (NASDAQ:MOR) stock is increasing more than 19% in pre-market trading on Wednesday.
- India Globalization Capital (NYSEMKT:IGC) shares are getting an almost 19% boost this morning.
- TCR2 Therapeutics (NASDAQ:TCRR) stock is jumping over 17% alongside the release of clinical trial results.
- Longeveron (NASDAQ:LGVN) shares are up more than 17% in Wednesday morning trading.
- 阿特裡斯機動車輛(納斯達克:AMV)股價在首次公開募股(IPO)後反彈,漲幅超過186%。
- 思洛製藥(納斯達克:豎井)在納斯達克交易所上市後,股價上漲了78%以上。
- 普羅塞納公司(納斯達克:PRTA)股價飆升超過64%,同時競爭對手的阿爾茨海默氏症藥物數據也呈陽性。
- 生物遺傳研究(納斯達克:BIIB)股價上漲超過43%,因為它是發佈阿爾茨海默氏症藥物數據的競爭對手。
- Acumen製藥公司(納斯達克:ABOS)股價飆升超過29%,因為它也加入了阿爾茨海默氏症藥物的反彈。
- BiomX(紐約時報:PHGE)股價在退市前攀升了27%以上特拉維夫證券交易所下週。
- 睡眠症(納斯達克:更多)週三盤前交易中,股價漲幅超過19%。
- 印度全球化資本(紐約時報:IGC)今天上午,股價上漲了近19%。
- TCR2治療公司(納斯達克:TCRR)隨著臨床試驗結果的公佈,股價躍升了17%以上。
- 龍威龍(納斯達克:LGVN)股價在週三早盤交易中上漲逾17%。
10 Top Losers
十大失敗者
- Mind Medicine (NASDAQ:MNMD) stock is plummeting over 35% after pricing a public stock offering.
- iBio (NYSEMKT:IBIO) shares are diving close to 33% with the release of preliminary results for fiscal Q4.
- Nano Labs (NASDAQ:NA) stock is tumbling more than 21% after revealing the pricing of a public stock offering.
- Gamida Cell (NASDAQ:GMDA) shares are taking a nearly 21% beating as it also priced a public stock offering.
- Powerbridge Technologies (NASDAQ:PBTS) stock is falling over 13% after rallying yesterday on NFT news.
- Avenue Therapeutics (NASDAQ:ATXI) shares are dropping more than 13% after rallying on Tuesday.
- EZGO Technologies (NASDAQ:EZGO) stock is sliding over 13% on no clear news today.
- MFA Financial (NYSE:MFA) shares are slipping more than 10% following two S-3ASR filings yesterday.
- Siyata Mobile (NASDAQ:SYTA) stock is dipping over 10% today.
- 9 Meters Biopharma (NASDAQ:NMTR) shares close out our pre-market stock movers down more than 9% following a rally yesterday on clinical trial data.
- 精神醫學(納斯達克:MNMD)在為公開募股定價後,股價暴跌超過35%。
- IBio(紐約時報:IBio)隨著第四財季初步業績的發佈,股價暴跌近33%。
- 納米實驗室(納斯達克:北美)在披露公開發行股票的定價後,股價暴跌超過21%。
- 伽米達細胞(納斯達克:GMDA)股價下跌近21%,因為該公司還為公開募股定價。
- 宏橋高科(納斯達克:PBTS)股價在昨天NFT的消息中反彈後,目前跌幅超過13%。
- 大道治療公司(納斯達克:ATXI)股價在週二反彈後下跌超過13%。
- 易電行(納斯達克:EZGO)股價在今天沒有明確消息的情況下下滑超過13%。
- MFA金融(紐約證券交易所:MFA在S-3ASR昨日提交兩份申請檔案後,其股價下跌超過10%。
- Siyata Mobile(納斯達克:SYTA)股票今天下跌了10%以上。
- 9米Biophma(納斯達克:NMTR)股價收盤前下跌超過9%,此前我們的臨床試驗數據昨天出現反彈。
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版日期,威廉·懷特他沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點,以InvestorPlace.com為準。出版指南。
The post Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
週三,《今日最大的盤前股票交易者:10大贏家和輸家》一文出現在InvestorPlace的首位。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧